REFERENCES
1. Ralston MR, McCreath G, Lees ZJ, et al. Beyond body mass index: exploring the role of visceral adipose tissue in intensive care unit outcomes. BJA Open. 2025;14:100391.
2. Goossens GH. The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function. Obes Facts. 2017;10:207-15.
3. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest. 2004;113:1582-8.
4. Emamat H, Jamshidi A, Farhadi A, Ghalandari H, Ghasemi M, Tangestani H. The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review. BMC Public Health. 2024;24:1827.
5. Cheng C, Yu X, Shi K, et al. Associations between abdominal obesity indices with hypertension in type 2 diabetes mellitus: Chinese visceral adiposity index. J Endocrinol Invest. 2024;47:547-55.
6. Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev. 2021;22:e13088.
7. Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21:360-5.
8. Kong M, Xu M, Zhou Y, et al. Assessing visceral obesity and abdominal adipose tissue distribution in healthy populations based on computed tomography: a large multicenter cross-sectional study. Front Nutr. 2022;9:871697.
9. Busetto L, Dicker D, Frühbeck G, et al. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30:2395-9.
10. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-9.
11. Ashwell M, Gibson S. Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet And Nutrition Survey of adults aged 19-64 years. Obes Facts. 2009;2:97-103.
12. Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221-62.
13. Zhou X, Li Y, Zhang X, et al. Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort. Diabetes Metab Res Rev. 2019;35:e3156.
14. Zhang F, Li Y, Zhao Y, Zhou X, Ji L. Is visceral abdominal fat area a better indicator for hyperglycemic risk? J Diabetes Investig. 2020;11:888-95.
15. Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987-92.
16. Zheng J, Hu Y, Xu H, et al. Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus-a multicenter study in China. Cardiovasc Diabetol. 2023;22:137.
17. Li X, Katashima M, Yasumasu T, Li KJ. Visceral fat area, waist circumference and metabolic risk factors in abdominally obese Chinese adults. Biomed Environ Sci. 2012;25:141-8.
18. Grundy SM, Cleeman JI, Daniels SR, et al; American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-52.
19. Lu Y, Zhang H, Lu J, et al; China Patient-Centered Evaluative Assessment of Cardiac Events Million Persons Project Collaborative Group. Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China. JAMA Netw Open. 2021;4:e2127573.
20. Atef HM, Korayem EM, Ahmed NA, Houseni MM, El-refaie AM, Gomaa MI. Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy. Egypt J Radiol Nucl Med. 2023;54:1165.
21. Speliotes EK, Massaro JM, Hoffmann U, et al. Liver fat is reproducibly measured using computed tomography in the Framingham heart study. J Gastroenterol Hepatol. 2008;23:894-9.
22. Iwasaki M, Takada Y, Hayashi M, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation. 2004;78:1501-5.
23. Liu L, Feng J, Zhang G, et al. Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes. Curr Med Res Opin. 2018;34:123-9.
24. Lee YH, Park J, Min S, Kang O, Kwon H, Oh SW. Impact of visceral obesity on the risk of incident metabolic syndrome in metabolically healthy normal weight and overweight groups: a longitudinal cohort study in Korea. Korean J Fam Med. 2020;41:229-36.
25. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86:353-9.
26. Gadekar T, Dudeja P, Basu I, Vashisht S, Mukherji S. Correlation of visceral body fat with waist-hip ratio, waist circumference and body mass index in healthy adults: a cross sectional study. Med J Armed Forces India. 2020;76:41-6.
27. Parente EB, Mutter S, Harjutsalo V, Ahola AJ, Forsblom C, Groop PH. Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes. Sci Rep. 2020;10:18575.
28. Tuglo LS. Comparison of adiposity anthropometric indices and their associations with visceral fat levels determined by bioelectrical impedance analysis among diabetic patients. Sci Rep. 2022;12:17824.
